Patent Issued for Formulations for oral administration of active agents (USPTO 12076373).

A patent has been issued to Entera Bio Ltd. for formulations and systems for oral administration of therapeutically active agents, such as proteins. The patent describes a pharmaceutical composition for oral administration that includes a therapeutically active agent, an antacid compound, and an absorption enhancer. The composition is formulated as a solid unit dosage form that is soluble in gastric fluid. This invention aims to address the challenges of degradation and poor absorption of large molecules in the digestive system. [Extracted from the article]